Breast Cancer
2026-07-06 · Department of Health and Social Care · HL1759 · Official question
Baroness Ritchie of Downpatrick
Question
To ask His Majesty's Government what assessment they have made of the medicines available to treat patients with HER2-low metastatic breast cancer.
Answer
HER2‑low breast cancer is managed with treatments for HER2‑negative breast cancer. The National Institute for Health and Care Excellence (NICE) has published guidance recommending a number of medicines for the treatment of HER2-negative breast cancer whic...